BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/11/2026 4:50:46 AM | Browse: 12 | Download: 21
 |
Received |
|
2025-08-04 06:00 |
|
Peer-Review Started |
|
2025-08-04 06:00 |
|
First Decision by Editorial Office Director |
|
2025-08-11 07:17 |
|
Return for Revision |
|
2025-08-11 07:17 |
|
Revised |
|
2025-08-24 17:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-03 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-03 09:42 |
|
Articles in Press |
|
2025-12-03 09:42 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-04 00:10 |
|
Publish the Manuscript Online |
|
2026-02-11 03:41 |
| ISSN |
2150-5349 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Artificial intelligence in the management of inflammatory bowel disease: What’s next?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Anthony J Bilotta, Jennifer A Trebilcock, Nicholas J Hebda, Charanpreet K Sasan, Katherine M Cooper and Abbas H Rupawala |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Katherine M Cooper, MD, Department of Medicine, UMass Chan Medical School, 55 Lake Ave North, Worcester, MA 01655, United States. katherine.cooper@umassmed.edu |
| Key Words |
Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Artificial intelligence; Machine learning; Deep learning |
| Core Tip |
Inflammatory bowel disease (IBD) is a chronic relapsing-remitting autoimmune disorder of the gastrointestinal tract. The management of IBD is complex and relies on subjective interpretation of invasive and non-invasive assessments to guide therapeutic decisions. Artificial intelligence (AI) is emerging as a potential tool to standardize the assessment of IBD and personalize therapeutic selection. This article highlights recent advances in AI in IBD with a focus on endoscopy, non-invasive imaging, histology, AI chatbots, therapeutic prediction models and current barriers to widespread implementation of AI in clinical practice. |
| Publish Date |
2026-02-11 03:41 |
| Citation |
Bilotta AJ, Trebilcock JA, Hebda NJ, Sasan CK, Cooper KM, Rupawala AH. Artificial intelligence in the management of inflammatory bowel disease: What’s next? World J Gastrointest Pharmacol Ther 2026; 17(1): 112640 |
| URL |
https://www.wjgnet.com/2150-5349/full/v17/i1/112640.htm |
| DOI |
https://dx.doi.org/10.4292/wjgpt.v17.i1.112640 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
